558 results on '"Faraci, Maura"'
Search Results
102. Imatinib melylate as second‐line treatment of bronchiolitis obliterans after allogenic hematopoietic stem cell transplantation in children
103. Telomere length of donors influences granulocyte recovery in children after hematopoietic stem cell transplantation
104. Failures of once‐a‐week trimethoprim‐sulfamethoxazole prophylaxis in children undergoing allogeneic hematopoietic stem cell transplant
105. Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT
106. An unusual pattern of B-cell immunological reconstitution after allogeneic stem cell transplantation: A possible correlation with CMV reactivation?
107. Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency
108. Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: Report from the EBMT Paediatric Diseases and Late Effects Working Parties
109. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation
110. Unrelated HSCT in an adolescent affected by congenital erythropoietic porphyria
111. Additional file 1: of Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders
112. Additional file 2: of Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders
113. Three consecutive related bone marrow transplants for juvenile myelomonocytic leukaemia
114. Role of active follow-up for early diagnosis of relapse after elective end of therapies
115. CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective multicenter study.
116. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation
117. Uneventful outcome of unrelated hematopoietic stem cell transplantation in a patient with leukemic transformation of Kostmann syndrome and long-lasting invasive pulmonary mycosis
118. Evaluation of Chimerism Dynamics after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Nonmalignant Diseases
119. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
120. Thalidomide as treatment of crohn‐like disease occurred after allogeneic hematopoietic stem cell transplantation in a pediatric patient.
121. Ruxolitinib in Pediatric Patients with Treatment-Naïveor Steroid-Refractory Acute Graft-Versus-Host Disease: Primary Findings from the Phase I/II REACH4 Study
122. Stem Cell Transplantation in Children and Adolescents with Reduced Intensity Conditioning - a Multicentric Prospective Trial
123. Pneumocystis jirovecii pneumonia prophylaxis in hematopoietic stem cell transplantation, is it acceptable to wait for the engraftment for restarting it?
124. Etanercept as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients
125. Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry
126. Magnusiomyces clavatus infection in a child after allogeneic hematotopoetic stem cell transplantation: Diagnostic and therapeutic implications
127. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association–Hematopoietic Stem Cell Transplantation Group
128. Outcome of Transformed Fanconi Anaemia Patients after Hematopoietic Stem Cell Transplantation: Analysis on Behalf of European Group for Blood and Marrow Transplantation
129. Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT
130. Impact of in Vivo Lymphodepletion on Outcome in Children with Nonmalignant Disorders Receiving Peripheral Blood Stem Cell Transplantation
131. Multifactorial Posterior Reversible Encephalopathy Syndrome in Children: Clinical, Laboratory, and Neuroimaging Findings.
132. 131I‐Meta‐iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high‐risk neuroblastoma.
133. 197 - Treatment (Tx) Duration, Symptom Resolution, and Survival in Defibrotide (DF)-Treated Patients (pts) with Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Cell Transplantation (HCT): Analysis of a Multinational, Prospective, Observational Registry Study
134. Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita
135. Alternate-day dosing of posaconazole tablets in children leads to efficient plasma levels
136. RAG deficiency with ALPS features successfully treated with TCRαβ/CD19 cell depleted haploidentical stem cell transplant
137. CD70 Deficiency due to a Novel Mutation in a Patient with Severe Chronic EBV Infection Presenting As a Periodic Fever
138. Colistin Area Under the Time–Concentration in Children Treated With Intravenous Loading Dose and Maintenance Therapy
139. Monitoring of Busulphan Concentrations in Children Undergone Hematopoietic Stem Cell Transplantation: Unicentric Experience over 10 years
140. Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients
141. Toxic Epidermal Necrolysis-like Reaction After Hematopoietic Stem Cell Transplantation in Children
142. Epidemiology of invasive fungal diseases in children with solid tumours undergoing autologous haematopoietic stem cell transplantation: a 10-year experience in a tertiary Italian centre
143. Provision of Long-Term Monitoring and Late Effects Services Following Hematopoietic Cell Transplantation (HCT): A Survey of European Programs By the Complications and Quality of Life Working Party of the EBMT
144. Fertility Preservation in Pediatric and Adolescent Patients Undergoing HSCT: a Cross-Sectional Survey of the EBMT Pediatric WP
145. Single-Lineage Bone Marrow Failure Driven By 2 Novel PI3KCD Mutations
146. Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)
147. Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant.
148. Role of Acute Graft-Versus-Host Disease in the Risk of Bacteremia and Invasive Fungal Disease after Allogeneic Hemopoietic Stem Cell Transplantation in Children. Results from a Single-Center Observational Study
149. Risk of Seizures in Children Receiving Busulphan-Containing Regimens for Stem Cell Transplantation
150. Candida infections in paediatrics: Results from a prospective single‐centre study in a tertiary care children's hospital
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.